Now Reading: CDSCO warns against indiscriminate use of painkillers, antibiotics
-
01
CDSCO warns against indiscriminate use of painkillers, antibiotics
The Central Drugs Standard Control Organisation has issued a fresh advisory cautioning against the indiscriminate use of painkillers and antibiotics, warning that repeated and prolonged use without medical supervision can lead to…
The Central Drugs Standard Control Organisation has issued a fresh advisory cautioning against the indiscriminate use of painkillers and antibiotics, warning that repeated and prolonged use without medical supervision can lead to kidney complications. In a circular dated 21 September, 2026, the drug regulator reminded the public that non-steroidal anti-inflammatory drugs and antibiotics are prescription medicines under the Drugs and Cosmetics Rules and must be used only when clinically indicated.
The CDSCO asked people not to take these drugs repeatedly or for long periods without consulting a doctor. Those with existing kidney disease or other risk factors for renal impairment should inform their doctor before using NSAIDs. Doctors have been advised to prescribe the lowest effective dose for the shortest appropriate duration, especially for patients at higher risk of kidney injury. A 2025 review estimated the prevalence of chronic kidney disease in India at 13.24%.
Indian Opinion Analysis
Both sources faithfully report the CDSCO circular. Times of India leads with the kidney risk and a prevalence figure of 13.24% for chronic kidney disease, framing the advisory as a response to a specific public health burden. Times Now News leads with the regulatory reminder and includes clinical details on kidney injury drawn from an American journal. The difference is one of emphasis: the former contextualises the warning with domestic disease data, the latter with medical mechanism. Neither is pro-government or critical, both are straightforward health advisories. Readers should note that actual compliance with the advisory, not just its issuance, will determine its impact.
Coverage: 2 sources, 2 neutral
Sources (2): timesofindia.indiatimes.com (neutral report), timesnownews.com (neutral report)
This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry.
Updated: this story now draws on 2 sources.
